The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Company Pte Ltd
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aceso Company Pte. Ltd., a Singapore-based non-promoter entity, sold 79,66,310 equity shares (~5.65% of total share capital on a fully diluted basis) of HealthCare Global Enterprises Ltd (HCG) through on-market trades on 10 and 11 September 2025. Before the sale, Aceso held 79,75,301 shares (~5.65%); after the sale, its holding has dropped to just 8,991 shares (~0.006%), meaning the entity has effectively exited the company. The total share capital of HCG remains unchanged at 13,94,15,370 shares. The mode of sale was open market, and the disclosure was filed under SEBI's takeover regulations to report a change in shareholding beyond the 2% creeping threshold.
A near-complete exit by a non-promoter institutional holder could create short-term selling pressure on HCG stock and signal reduced institutional confidence. Shareholders should watch for further disclosures, as such large on-market sales often lead to temporary price weakness and may trigger follow-up exits by other holders.